Stocktoria
Apogee Therapeutics, Inc. APGE
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-07-14
Apogee Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,742,549 | $107.9M | 4.01% |
| CITADEL ADVISORS LLC | 652,602 | $54.9M | 0.95% |
| TWO SIGMA INVESTMENTS, LP | 281,386 | $23.7M | 0.41% |
| MILLENNIUM MANAGEMENT LLC | 92,592 | $7.8M | 0.14% |
| D. E. Shaw & Co., Inc. | 58,835 | $5.0M | 0.09% |
| Point72 Asset Management, L.P. | 13,800 | $1.2M | 0.02% |
| AQR CAPITAL MANAGEMENT LLC | 8,027 | $675,633 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.